More articles from Original Articles: Interstitial lung disease

Pirfenidone in idiopathic pulmonary fibrosis
H. Taniguchi, M. Ebina, Y. Kondoh, T. Ogura, A. Azuma, M. Suga, Y. Taguchi, H. Takahashi, K. Nakata, A. Sato, M. Takeuchi, G. Raghu, S. Kudoh, T. Nukiwa, the Pirfenidone Clinical Study Group in Japan

European Respiratory Journal Apr 2010, 35 (4) 821-829; DOI: 10.1183/09031936.00005209
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
C. J. Zappala, P. I. Latsi, A. G. Nicholson, T. V. Colby, D. Cramer, E. A. Renzoni, D. M. Hansell, R. M. du Bois, A. U. Wells

European Respiratory Journal Apr 2010, 35 (4) 830-836; DOI: 10.1183/09031936.00155108
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)
G. Raghu, T. E. King, J. Behr, K. K. Brown, R. M. du Bois, I. Leconte, S. Roux, J. Swigris

European Respiratory Journal Jan 2010, 35 (1) 118-123; DOI: 10.1183/09031936.00188108
Suberoylanilide hydroxamic acid: a potential epigenetic therapeutic agent for lung fibrosis?
Z. Wang, C. Chen, S. N. Finger, S. d/o Kwajah M.M, M. Jung, H. Schwarz, N. Swanson, R. R. Lareu, M. Raghunath

European Respiratory Journal Jul 2009, 34 (1) 145-155; DOI: 10.1183/09031936.00084808
MMP expression and abnormal lung permeability are important determinants of outcome in IPF
S. McKeown, A. G. Richter, C. O'Kane, D. F. McAuley, D. R. Thickett

European Respiratory Journal Jan 2009, 33 (1) 77-84; DOI: 10.1183/09031936.00060708
Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia
I. N. Park, Y. Jegal, D. S. Kim, K-H. Do, B. Yoo, T. S. Shim, C-M. Lim, S. D. Lee, Y. Koh, W. S. Kim, W. D. Kim, S. J. Jang, M. Kitaichi, A. G. Nicholson, T. V. Colby

European Respiratory Journal Jan 2009, 33 (1) 68-76; DOI: 10.1183/09031936.00158507
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
A. Fabre, J. Marchal-Sommé, S. Marchand-Adam, C. Quesnel, R. Borie, M. Dehoux, C. Ruffié, J. Callebert, J-M. Launay, D. Hénin, P. Soler, B. Crestani

European Respiratory Journal Aug 2008, 32 (2) 426-436; DOI: 10.1183/09031936.00126907
Increased urinary leukotriene E₄ concentration in patients with eosinophilic pneumonia
E. Ono, M. Taniguchi, H. Mita, N. Higashi, Y. Fukutomi, H. Tanimoto, K. Sekiya, C. Oshikata, T. Tsuburai, N. Tsurikisawa, M. Otomo, Y. Maeda, O. Matsuno, E. Miyazaki, T. Kumamoto, K. Akiyama

European Respiratory Journal Aug 2008, 32 (2) 437-442; DOI: 10.1183/09031936.00093407
Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
C. E. Daniels, E. S. Yi, J. H. Ryu

European Respiratory Journal Jul 2008, 32 (1) 170-174; DOI: 10.1183/09031936.00176307
Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis
Q. Ye, Y. Dalavanga, N. Poulakis, S. U. Sixt, J. Guzman, U. Costabel

European Respiratory Journal May 2008, 31 (5) 1030-1036; DOI: 10.1183/09031936.00125407

Main menu

User menu

Search

More articles from Original Articles: Interstitial lung disease

Pages

Contact us